A single-center, single-blind phase II clinical trial of intradermal microneedles for the prevention and treatment of abdominal pain caused by acute pancreatitis in pregnancy

Clinical application of intradermal microneedles for abdominal pain in patients with acute pancreatitis in pregnancy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400079433

Enrollment

Unknown

Registered

2024-01-03

Start date

2024-01-03

Completion date

Unknown

Last updated

2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal pain caused by acute pancreatitis in pregnancy

Interventions

treatment group:Routine internal medicine treatment+ Intradermal microneedles

control group:Routine internal medicine treatment

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Meet the diagnostic criteria for acute pancreatitis, and in the pregnancy period; ?The patient had abdominal pain, and the international digital grading (NRS) score was greater than 3 points; ?Patients signed an informed consent form, and showed a high degree of cooperation.

Exclusion criteria

Exclusion criteria: ? Critically ill patients in need of mechanical ventilation by tracheal intubation or ICU treatment; ? Patients with heart disease and high nervous tension; ? Patients with chronic pancreatitis and diagnosed pancreatic cancer.

Design outcomes

Primary

Measure	Time frame
Pain score;	—

Secondary

Measure	Time frame
hospital stay;	—

Countries

China

Contacts

Public ContactZhao Xianlin

West China Hospitall, Sichuan University/West China School of Medicine, Sichuan University

zhaoxianlin@wchscu.edu.cn+86 135 4815 8828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026